Protara Therapeutics (TARA) Other Non Operating Income (2013 - 2025)

Protara Therapeutics' (TARA) quarterly Other Non Operating Income came in at $249000.0 in Q4 2025, down 48.23% on a QoQ basis from $481000.0 in Q1 2025.

Protara Therapeutics (TARA) Other Non Operating Income (2013 - 2025) Analysis & Trends

Protara Therapeutics (TARA) has 8 years of Other Non Operating Income data on file, last reported at $249000.0 in Q4 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A year-over-year to $249000.0 in Q4 2025; TTM through Dec 2025 was $730000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $730000.0, up 88.63% from the prior year.
  • Other Non Operating Income for Q4 2025 stood at $249000.0, down from $481000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for TARA reached as high as $481000.0 in Q1 2025 and fell as low as $249000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Protara Therapeutics 233.61 Mn 233.61 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 249,000.00
Mar 31, 2025 481,000.00
Sep 30, 2019 2,000.00
Jun 30, 2019 -2,000.00
Mar 31, 2019 1,000.00
Sep 30, 2018 -1,000.00
Jun 30, 2018 15,000.00
Mar 31, 2018 192,000.00
Sep 30, 2017 -84,000.00
Jun 30, 2017 332,000.00
Mar 31, 2017 -50,000.00
Sep 30, 2016 -4,000.00
Jun 30, 2016 -63,000.00
Mar 31, 2016 6,000.00
Dec 31, 2015 4.65 Mn
Sep 30, 2015 -335,000.00
Jun 30, 2015 -14,000.00
Dec 31, 2014 10.50 Mn
Sep 30, 2014 -5.33 Mn
Jun 30, 2014 -29,000.00